Pfizer, Inc. - Celebrex, Bextra

This pharmaceutical company allegedly used deceptive advertising regarding the efficacy of Celebrex and Bextra in violation of the Tennessee Consumer Protection Act. This was a multistate case. The State of Tennessee received $990,911.00 of the total $60 million paid by Pfizer in the settlement.

Press Release

• Tennessee Attorney General Files Judgment with Pfizer Inc. Resolving Allegations of Deceptive Marketing of Bextra and Celebrex (#08-42, October 22, 2008)

State Court Filings in Pfizer - Celebrex, Bextra

• State of Tennessee's Complaint for Permanent Injunction and Other Relief (October 22, 2008)
• Agreed Final Judgment (October 22, 2008)

This list includes only significant filings and is not intended to be a complete record of the matter.